Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. - Wikidata - awgldk - TriplyDB

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.

http://www.wikidata.org/entity/Q44621485

about

Sublingual immunotherapy for asthma Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study.Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.Immunotherapy for house dust mite sensitivity: where are the knowledge gaps?Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials.A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis Long-term adherence to sublingual therapy: literature review and suggestions for management strategies based on patients' needs and preferences.Progress in the development of specific immunotherapies for house dust mite allergies.A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).Sublingual allergen immunotherapy for respiratory allergies: what is new?Current developments for improving efficacy of allergy vaccines.Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations.Is clinical tolerance possible after allergen immunotherapy?Pharmacodynamic and pharmacokinetic evaluation of house dust mite sublingually administered immunotherapy tablet in the treatment of asthma.SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis.Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.Immunotherapy in allergic rhinitis and lower airway outcomes.300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.Allergen immunotherapy in asthma; what is new?Investigational new drugs for allergic rhinitis.Comparison of six disease severity scores for allergic rhinitis against pollen counts a prospective analysis at population and individual level.Outcome of sublingual immunotherapy in patients with allergic rhinitis sensitive to house dust mites.Immunotherapy of house dust mite allergy.Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.Efficacy of sublingual immunotherapy for house dust mite allergic rhinitis.A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients.[Respiratory allergies in children and adolescents: the role of component-resolved diagnosis and specific immunotherapy].

P2860

Q24187736-D20106AA-4D21-408F-8FB6-23E1B4E503E7 Q26772069-3ECB071F-0968-4F94-A288-C58469039181 Q28082353-FB129EEB-2CBB-4416-A2C6-EF0D955F0C16 Q30239093-CE7FD003-3774-41E9-A2AC-AC5B9C9838FA Q30276174-E54181D4-4A6D-4124-A3F4-F01C372C3CDF Q33572979-C712A5B3-ADF1-425A-8EA8-8354950E856C Q34445398-093BD74D-8A0D-4736-8032-A0AE4BEFF969 Q35777126-47E24348-3F1F-4D47-A01E-4F97362B8153 Q36308157-22F03F11-79C3-42F6-B94D-F4AB7E95AFC2 Q37565596-10D126FF-8427-47D6-996D-818550E447BF Q37663911-A4B2658B-2C41-439C-815A-1610BFF5EFDC Q38224209-2758B948-CFA4-480D-AFA0-517EDD268A99 Q38245974-AEF45EE6-F57E-4961-AF64-6E9514FE1BCF Q38262772-FAC21F67-F685-4368-8FB1-57195ACD31CD Q38269285-476089DC-300A-4439-9383-A40DC438835C Q38503330-F3F8E02B-EBC3-4D22-A2F7-3021E9DF2DF3 Q38533962-8B5C02DB-60BE-4129-89CA-41D6DCD69A7F Q38542313-2D295154-44C9-4C2F-A0FD-A9CDD16DA36C Q38632661-F9F8DE93-C0C4-43D8-BFEE-DCD523FC1FF0 Q38703818-49432FAA-72DB-484A-860D-9E6CD894E03C Q38745619-AE473C34-BB7F-44AE-9D60-C87CF9C47FCC Q38792200-53D7E1A3-B59B-4FB7-B5B1-EF7FC42ABE1A Q38870647-CF211F6C-01C8-4C77-B724-AEB2B9AC03B8 Q38888019-D9874236-DAF5-45F7-AA3C-C5454F17787D Q38903486-B8025869-4AF3-4DA8-9709-0BF2A90D40F3 Q38955332-D16C293F-0B9A-4697-82EC-B99A656750D9 Q39038000-7EDC51E6-FBCF-4268-8AC9-8640992A1BE8 Q39111947-4111EC96-9A8A-411F-8E2D-5E4112B95519 Q39908406-95A639DD-53D2-416D-AEEC-8A336482A112 Q42024889-495A407D-F094-49EC-9122-B05CFCD50E46 Q43915564-14E07CA7-27AA-43C7-B428-830F69813D5F Q46651312-20062D33-F02D-438A-AF64-42CED49F2CE6 Q47713994-AC6C08C6-A783-41B3-B294-F7C5395C5EF4 Q47741028-04316C43-769C-4461-B926-8CC2459CD45A Q47761576-9E6C23AE-4FC0-49BA-B2DE-E2B3BD8E7D55 Q47764778-0F64FCC3-B38A-4449-9FE1-35AC8E3982CE Q47943200-F8A41290-37AF-4C28-9284-599AD6870D5A Q48056038-FFD6C555-7E6D-480C-840A-8397CCE0D192 Q49073680-9F388E66-5EE8-467F-9E2A-B451FBEF0140 Q52813186-BB6CB239-1736-47FE-94B0-CC234C9FF3ED

P2860

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.

http://www.wikidata.org/entity/Q44621485

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Efficacy and safety of subling ...... adults with allergic rhinitis.

@en

Efficacy and safety of subling ...... adults with allergic rhinitis.

@nl

type

label

Efficacy and safety of subling ...... adults with allergic rhinitis.

@en

Efficacy and safety of subling ...... adults with allergic rhinitis.

@nl

prefLabel

Efficacy and safety of subling ...... adults with allergic rhinitis.

@en

Efficacy and safety of subling ...... adults with allergic rhinitis.

@nl

P1433

Q44621485-2CFC92D7-3F65-460A-AFA3-3B574E583B39

P1476

Q44621485-8F159432-FDED-4697-8AE8-3355155C48C9

P2093

Q44621485-29A79151-B007-444E-A899-1D19034CD76C

Q44621485-2D1E7C85-9FC7-432E-804A-B5497A77ABB2

Q44621485-37E4D338-78CA-4755-A428-A2A8823FC96A

Q44621485-47641295-915E-4167-8AF1-DC1DCB7E71AB

Q44621485-916FE648-F47F-43D3-882A-BA3CBE8BA1E2

Q44621485-B9D24725-114E-4400-82EF-BC39DE0B1D46

Q44621485-DD435142-B521-4A94-B41B-48B88C2DD659

P304

Q44621485-BB1531BA-B78F-403A-831D-6DCB35B3B8C2

P31

Q44621485-C4425C96-ABDF-447D-8495-5490659BD401

P356

Q44621485-6EEC979A-6295-45CB-87CE-329D06C771CB

P407

Q44621485-5E475CEA-BB81-484E-8906-F049FF28E307

P433

Q44621485-03877D32-7ACA-40A6-AD0D-F50AB3F7E940

P478

Q44621485-5A533952-9F84-4C58-AFE4-309D5F4A95E1

P50

Q44621485-9C43B407-6C50-4484-8410-E86DC12B6321

Q44621485-D4CFC84F-EE6C-4AF4-80A7-FA1D30058F88

P577

Q44621485-D99D95D5-E56B-4ADC-8237-27E56DB6AB70

P698

Q44621485-5DF7AD11-687F-439C-9F13-52EEC9B5E6E1

P356

J.JACI.2013.11.012

P1433

The Journal of Allergy and Clinical Immunology

P1476

Efficacy and safety of subling ...... adults with allergic rhinitis.

@en

P2093

Ana I Tabar

http://www.w3.org/2001/XMLSchema#string

Armelle Montagut

http://www.w3.org/2001/XMLSchema#string

Hélène Nguyen

http://www.w3.org/2001/XMLSchema#string

Pascal Demoly

http://www.w3.org/2001/XMLSchema#string

Robert K Zeldin

http://www.w3.org/2001/XMLSchema#string

Teresa Carrillo

http://www.w3.org/2001/XMLSchema#string

Wytske J Fokkens

http://www.w3.org/2001/XMLSchema#string

P304

1608-14.e6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2013.11.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Karl-Christian Bergmann

P577

2013-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24388010

http://www.w3.org/2001/XMLSchema#string